Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data
- PMID: 17548132
- DOI: 10.1016/j.vaccine.2007.04.056
Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data
Similar articles
-
Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.Vaccine. 2007 Aug 1;25(31):5839-57. doi: 10.1016/j.vaccine.2007.04.062. Epub 2007 May 8. Vaccine. 2007. PMID: 17553602 No abstract available.
-
Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.Vaccine. 2007 Aug 1;25(31):5803-20. doi: 10.1016/j.vaccine.2007.04.059. Epub 2007 May 11. Vaccine. 2007. PMID: 17548135 No abstract available.
-
Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.Vaccine. 2007 Aug 1;25(31):5821-38. doi: 10.1016/j.vaccine.2007.04.057. Epub 2007 May 11. Vaccine. 2007. PMID: 17540485 No abstract available.
-
Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.Vaccine. 2004 Jan 26;22(5-6):575-85. doi: 10.1016/j.vaccine.2003.09.005. Vaccine. 2004. PMID: 14741147 Review. No abstract available.
-
Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.Vaccine. 2004 Jan 26;22(5-6):551-6. doi: 10.1016/j.vaccine.2003.09.007. Vaccine. 2004. PMID: 14741143 Review. No abstract available.
Cited by
-
Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.Trials. 2022 Feb 7;23(1):121. doi: 10.1186/s13063-021-05874-6. Trials. 2022. PMID: 35130946 Free PMC article. Clinical Trial.
-
OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.BMJ Open. 2020 Dec 17;10(12):e042838. doi: 10.1136/bmjopen-2020-042838. BMJ Open. 2020. PMID: 33334840 Free PMC article.
-
Post Marketing Surveillance Study of 2nd Dose Quadrivalent Human Papilloma Virus Vaccine in Elementary School Children in Jakarta, Indonesia: Safety Result and Implementation of School-Based HPV Immunization Program.Asian Pac J Cancer Prev. 2019 Mar 26;20(3):869-875. doi: 10.31557/APJCP.2019.20.3.869. Asian Pac J Cancer Prev. 2019. PMID: 30912406 Free PMC article.
-
Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.Vaccine. 2017 Dec 4;35(48 Pt A):6472-6482. doi: 10.1016/j.vaccine.2017.01.044. Vaccine. 2017. PMID: 29150052 Free PMC article. No abstract available.
-
A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants.Hum Vaccin Immunother. 2017 Sep 2;13(9):2025-2031. doi: 10.1080/21645515.2017.1342020. Epub 2017 Jul 12. Hum Vaccin Immunother. 2017. PMID: 28700282 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical